top of page

NEWS & UPDATES
Search


The Future of Weight-Loss Drugs: Innovation, Caution, and the Role of Nutritional Supplements
n the twenty-first century, the pursuit of a healthier body has entered a new technological era. From AI-driven metabolic tracking to groundbreaking injectable medications that mimic natural hormones, science is reshaping how people manage their weight. Yet, as the market for weight-loss drugs grows at an unprecedented rate, a critical question emerges: Are we moving toward genuine health—or merely outsourcing discipline to chemistry? This article explores the promise and per
Oct 24


Cholesterol at the Frontier of Science: New Insights and Implications
Cholesterol has long been a key concept in cardiovascular health — especially the role of low-density lipoprotein cholesterol (LDL-C) often labelled the “bad cholesterol.” However, recent scientific advances are reshaping our understanding of cholesterol metabolism, atherosclerotic risk, and how lifestyle plus supplemental strategies may contribute to management. Evolving Mechanistic Understanding Traditionally, elevated LDL-C levels were viewed simply as a risk marker for at
Oct 22


🧠 Weight Management and Hypothalamic Microinflammation: The Neuroscience of Modern Obesity
1. A Paradigm Shift: Obesity as a Neuroinflammatory Condition For decades, obesity was viewed as a simple imbalance between calories consumed and calories expended. However, recent neuroscience has reframed it as a metabolic–neuroinflammatory disease , in which low-grade inflammation in the hypothalamus —the brain’s key energy-regulation center—plays a pivotal role. When individuals consume excessive saturated fats, refined sugars, and ultra-processed foods , immune cells in
Oct 20


🫁 Pfizer’s New Breakthrough in Lung Cancer: Precision Medicine and Nutritional Support for Lung Health
1. A New Frontier in Lung Cancer Treatment Lung cancer remains one of the world’s leading causes of cancer-related deaths, responsible for more than 1.8 million fatalities per year . Yet the landscape of treatment is evolving rapidly — from generic chemotherapy to genetically targeted precision medicine . In early 2025, Pfizer announced a significant advancement in this field. Its drug combination — BRAFTOVI® (encorafenib) and MEKTOVI® (binimetinib) — demonstrated long-ter
Oct 19


Rethinking Obesity: How Genes, Metabolism, and Nutrition Interact in the New Era of Health Science
A Genetic Paradox: The Gene That Causes Obesity — and Protects the Heart In a groundbreaking Nature report, researchers have identified a genetic variant that reshapes how we think about obesity and heart health. The study found that certain variants of the MC4R gene (melanocortin 4 receptor) are strongly linked to obesity — yet surprisingly, individuals carrying these variants showed lower cholesterol levels and reduced risk of cardiovascular disease . Traditionally, obesi
Oct 16


Ivermectin: A Potential Anticancer Drug Derived from an Antiparasitic Agent
From Humble Beginnings: The Evolution of Ivermectin Discovered in the late 1970s as a natural fermentation product of Streptomyces avermitilis , ivermectin quickly revolutionized global medicine as a powerful antiparasitic. It earned a Nobel Prize in 2015 for its impact on human and veterinary health, eliminating river blindness and lymphatic filariasis in millions. Yet, in the quiet corners of biomedical research, ivermectin has begun to reveal another, unexpected face — one
Oct 15
bottom of page









